CHEMICALS SUMMARY PAGE

Epoetin

Summary Information
Classification Chemicals / Complex Chemical Agents / Type:

(This chemicals section is currently predominantly used in Wildpro to link different data types and demonstrate inter-relationships. It does not contain detailed information on the chemical itself.)

Alternative Names
  • Epoetin alfa
  • Epoetin beta
  • Recombinant human erythropoetin

Notes Information in this page has been entered to support the current volumes of Wildpro and further information will be added as new volumes are completed. This page is not intended to substitute for the manufacturer's data sheet and the information is not yet complete for all species, or for all contra-indications etc.

CAUTION: Before any pharmaceutical product is used, the manufacturer's data sheet, containing information on uses, dosage and administration, contra-indications, warnings etc., should always be consulted. It is important to remember that licensing of pharmaceutical products for use in a particular species/condition, as well as mandatory meat and milk withdrawal times for food-producing animals, varies between countries and changes with time. Withdrawal times also may vary between different pharmaceutical formulations and depending on route of administration. In the EU, the prescription cascade must be followed (see LCofC1.2H and W564.Apr05.w1); note that specific restrictions apply for food-producing animals. In the USA, FARAD may be consulted regarding residues and meat and milk withdrawal times.

  • Erythropoietic agent; hormone which regulates erythropoesis. (B658)
  • Used in the treatment of anaemia associated with chronic renal failure. (B340.9.w9)
  • Monitor PCV to ensure this does not increase to above the normal range.
  • Some individuals may develop an immune-mediated response to this drug, reducing its efficacy. (B340)
  • Parenteral administration only; not absorbed following oral administration. (B658)
  • Contraindicated in individuals with uncontrolled hypertension. (B658)
Administration
  • Dogs and cats: 50 - 100 units/kg subcutaneously, three times weekly. Continue until PCV is within the normal range.  (B340.9.w9)

Great Apes

Return to Top of Page